ORIC Pharmaceuticals Profit Margin

ORIC Pharmaceuticals (ORIC) currently reports a profit margin of -Infinity% as of March 2026. That compares with -249.26% in the prior-year period — down Infinity% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore ORIC Pharmaceuticals's profit margin history and peer comparisons.

ORIC Pharmaceuticals's profit margin decreased from -249.26% to -Infinity% — a Infinity% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ORIC Pharmaceuticals's profit margin of -Infinity% is lower than the Healthcare sector average of 15.58%. That is roughly Infinity% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but ORIC Pharmaceuticals's current -Infinity% should be judged against Healthcare norms (sector average: 15.58%) and against ORIC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -Infinity%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for ORIC Pharmaceuticals, and consider following ORIC for alerts when major investors trade the stock.